LPCN

Lipocine Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↑ 6/10
  • Value↓ 0/10
Lipocine sales and earnings growth
LPCN Growth
Good
  • Revenue Y/Y↓ -82.35%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -644.34%
Lipocine gross and profit margin trends
LPCN Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -487.10%
  • ROIC 5Y↓ -43.69%
Lipocine net debt vs free cash flow
LPCN Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Lipocine stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗